“Characterisation of mutations in cytogenetically normal acute myeloid leukaemia patients with triple-negative FLT3-ITD/ NPM1/CEBPA subgroup using targeted next-generation sequencing”, Int. Med. Res. J., vol. 11, no. 1, Sep. 2026, doi: 10.63719/imrj.2025.11.01.003.